Skip to main content
. 2021 Jan;10(1):184–194. doi: 10.21037/tcr-20-2772

Figure 1.

Figure 1

Kaplan-Meier plot of OS in EGFR wild-type oligometastatic NSCLC patients with ECOG PS <2 or ≥2. OS, overall survival; EGFR, epidermal growth factor receptor; NSCLC, non-small cell lung cancer; ECOG PS, Eastern Cooperative Oncology Group performance status.